Research peptides, without the research

There is an odd fact at the center of the research peptide market. The products are labeled for research use only, and almost none of them are the subject of any research you could go and read.

For a few compounds the molecule is also an approved drug, and the evidence about that drug, made that way, is enormous. For most of the rest the published record is thin: some animal studies, perhaps an early-phase human trial that stalled a decade ago, a review article or two summarizing the same handful of papers. Meanwhile interest in these compounds has run far ahead of that record, and accounts of personal experience circulate by the thousand on forums and in group chats, where they are read as if they were evidence.

This piece is about that gap. Not because the label is dishonest, exactly, but because "research" has come to name a market rather than an activity, and the activity is what's missing.

Why anecdote isn't evidence

An account of what one person did and what happened next is not worthless. It is where most scientific questions start. But it can't answer them, for reasons that have nothing to do with the honesty of the person telling it.

There is no comparison. Without knowing what would have happened otherwise, nobody can tell whether the compound did anything. People also tend to change several things at once, and credit whichever one they were paying attention to.

Expectation does real work. This is the reason clinical trials are blinded: people who expect to feel different frequently do, and they report it faithfully.

The sample is self-selected. People who saw a striking result post about it. People who saw nothing mostly don't. People who had a bad experience often stop posting altogether. What's left online is the numerator of a fraction whose denominator nobody recorded.

And the input is unknown. This one is specific to this market. An account of an outcome is only informative if you know what went in, and most of the time nobody does. Was it the declared compound? At the labeled amount? From the same batch as the one the last person wrote about? As we argue elsewhere on this site, a certificate on a product page can't answer those questions. An outcome attached to an unverified product is an outcome attached to a question mark.

Why the record isn't being built

If the evidence is so thin, why isn't somebody producing it? Mostly because nobody is positioned to.

The compounds are old or unpatentable, so no company has a reason to fund trials. The makers of approved drugs have no interest in studying the gray market that sells their molecules. Academic research is slow, expensive and depends on grants that don't favor this field. Regulators' position is that the products aren't for people, which is not a research agenda. And sellers can't fund research without a conflict of interest that would poison whatever they found.

So the record is left to the forums, and forums don't accumulate. Threads get lost or deleted. Everyone asks slightly different questions and answers in slightly different words. Nobody counts the people who saw nothing. A question that was carefully discussed three years ago gets asked again from scratch, and answered from scratch, by different people with different products. It is a great deal of experience and almost no data, and the difference between the two is structure.

What an honest evidence base would take

We think it would take six things. None of them is exotic. All of them are missing.

1. Known inputs. Product that was independently tested, so that an outcome can be attached to a known compound in a known amount. This is why we care so much about testing the seller doesn't control. Without it, nothing downstream can be trusted either.
2. Structured records. The same questions, asked the same way, over time, so that accounts from different people can be compared instead of just collected.
3. Denominators. Recording the people who saw nothing and the people who stopped, not only the people with something to report. A signal is only a signal against a background.
4. Adverse events, kept. Anything unwanted, recorded at the time and never deleted when a thread dies or a mood shifts.
5. Independence. Collected by someone with nothing to gain from the answer: no seller, no affiliate revenue, no stake in any compound looking good.
6. Permanence and openness. A record that accumulates instead of resetting, and that actual researchers can use.

What such a record could and couldn't do

It would be observational data, and observational data has limits that no quantity of it removes. It can't establish that a compound works, or that it is safe, and anyone who says otherwise about data like this is overclaiming. What it can do is raise questions worth answering and flag patterns worth investigating. It can give the people who run real trials somewhere to look and a reason to look there. That is a modest claim, and it is the honest one.

The Foundation takes no position on whether any compound is good, safe or worth taking. This piece is not an argument that anyone should use anything. It is an argument that the questions people are already asking should eventually be answerable from evidence rather than argued from belief, and that this only happens if somebody builds a record that accumulates. That is the direction of the Foundation's work beyond certification. We'll say more when there is more to say.